CIAM
ATRC icon

Caitong International Asset Management’s AtriCure ATRC Stock Holding History

Caitong International Asset Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448 Buy
16
+9
+129% +$253 ﹤0.01% 1766
2026
Q1 		$200 Buy
7
+6
+600% +$205 ﹤0.01% 1879
2025
Q4 		$40 Sell
1
-21
-95% -$770 ﹤0.01% 1765
2025
Q3 		$776 Buy
+22
New +$758 ﹤0.01% 1500

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Caitong International Asset Management's ATRC Position: Q2 2026 in Review

Caitong International Asset Management increased its AtriCure (ATRC) stake by 129% in Q2 2026, buying an estimated $253 and bringing the position to 16 shares worth $448. The position accounts for ﹤0.01% of the portfolio, ranked #1766.

Caitong International Asset Management first reported a position in ATRC in Q3 2025 and has held it in 4 quarters since. The position peaked at $776 in Q3 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Caitong International Asset Management held 16 shares of AtriCure worth $448 as of Q2 2026.
  • Caitong International Asset Management bought 9 AtriCure shares in Q2 2026, an estimated $253.
  • AtriCure made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1766 holding.
  • Caitong International Asset Management first reported a position in AtriCure in Q3 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's AtriCure position peaked at $776 in Q3 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.